Dongkoo Bio&Pharma to be listed in KOSDAQ market after forecasting demands and subscribing
Dongkoo Bio&Pharma will go public in the middle of February after forecasting demands between 30 and 31 January and subscribing between 5 and 6 February. The organization of the listing is NH Investment & Securities.
Dongkoo Bio&Pharma, the largest prescription pharmaceutical company in the derm...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
